{"disease":{"id":"churg-strauss-syndrome","name":"churg strauss syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03557060","title":"NUCALA® Special Drug Use Investigation (EGPA, Long-term)","phase":"","overall_status":"COMPLETED","enrollment_count":4115,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT02020889","title":"A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":136,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT04671446","title":"Identification of Autoantigens in EGPA and Severe Eosinophilic Asthma","phase":"","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Queen Mary University of London","has_results":true},{"nct_id":"NCT04551989","title":"Mepolizumab Long-term Study to Assess Real World Safety and Effectiveness of Eosinophilic Granulomatosis With Polyangiitis (EGPA) in Japan","phase":"","overall_status":"COMPLETED","enrollment_count":118,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03298061","title":"Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03482479","title":"Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT03036670","title":"Eosinophilic Granulomatosis With Polyangiitis Cohort","phase":"","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Portsmouth Hospitals NHS Trust","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}